Antibe Therapeutics Inc(Pre-Merger) ATBPF

Level 3a

[Blazesb]

I expect the stock to stick around present levels until 3a approaches completion.

A year from now I suppose.  By then whatever normalizing by management of the ballyhooed 'significant' acetaminophen taint of the last phase of tests should be over.

[Inthepez]

You’re fu*king retarded and obviously spreading the same FUD but through a different account.  Here are a few things in the works before ph3: -FDA meeting -release of the secondary endpoints, including metabolic pathways -official release of the INN  -advancing 352 in clinical trials the list goes on. Please choke on a c*ck to help calm you down since you’re either panicking or

[MUGMODs]

This post has been removed in accordance with Community Policy

[Blazesb]

The thing about this list Pez is that it is already baked in to the shareprice.  All your sentiments right back atya. -FDA meeting -release of the secondary endpoints, including metabolic pathways -official release of the INN  -advancing 352 in clinical trialsnteresting list pez.  

[Inthepez]

If news came out now about 352 trials starting, price would likely increase.  Same if fda meeting date was announced etc. It’s not all “baked” in. Next should see some positive changes now that the BD closed.